Results 101 to 110 of about 1,751 (120)
Some of the next articles are maybe not open access.

Post-finasteride Syndrome: A Review of Current Literature

Current Sexual Health Reports, 2018
A constellation of persistent adverse effects—collectively termed post-finasteride syndrome (PFS)—after 5α-reductase inhibitor treatment for benign prostatic hyperplasia (BPH) and androgenic alopecia (AGA) has recently been described. The severity of these sexual, physical, neurological, and psychiatric side effects raises important concerns regarding ...
Jeffrey K. Than   +2 more
openaire   +1 more source

Trazodone by epigenetic mechanism can reverse the post finasteride syndrome

Magna Scientia Advanced Research and Reviews, 2023
The action mechanism of finasteride as inhibitor of the 5alpha-reductase enzyme in the brain could cause an epigenetic change imbalance in the messenger RNA of androgen receptor. The decrease of dihydrotestosterone (DHT) followed by an increase of free testosterone in the brain could in theory cause an imbalance in acetylation and methylation of ...
openaire   +1 more source

Trazodone associated with Clomiphene a proposal treatment for post finasteride syndrome

Magna Scientia Advanced Research and Reviews, 2023
Erectile dysfunction caused by medications are probably caused by the disconnection of synaptic circuits responsible for linking libido to erection. For instance, it is well known that sexual dysfunction may occur in patients treated with finasteride, an inhibitor of the enzyme 5alpha-reductase, prescribed for androgenetic alopecia and benign prostatic
openaire   +1 more source

Post-finasteride syndrome - a true clinical entity?

International Journal of Impotence Research
This review critically examines Post-Finasteride Syndrome (PFS), a condition eventually reported by men who have used finasteride for androgenetic alopecia or benign prostatic enlargement and experienced persistent adverse effects after discontinuation. We explore the clinical manifestations, including sexual dysfunction, neuropsychiatric symptoms, and
Simone Cilio   +4 more
openaire   +2 more sources

Post‐finasteride syndrome: real or myth?

Trends in Urology & Men's Health
Men who report persistent sexual, neurological, and psychological side‐effects after discontinuing finasteride are said to have post‐finasteride syndrome. It is uncommon, but difficult for men suffering its effects. Although controversial, with no proven treatments, the syndrome should not be ignored.
openaire   +1 more source

Post-Finasteride Syndrome

2022
Mary C. Fierro   +2 more
openaire   +1 more source

The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption

Current Sexual Health Reports, 2018
Post-finasteride syndrome (PFS) is a disorder characterized by a set of clinical symptoms experienced during use or after drug discontinuation. This cluster of symptoms encompasses overall sexual dysfunction (SD), erectile dysfunction (ED), loss of libido, depression, suicidal ideation, anxiety, panic attacks, insomnia, and cognitive dysfunction.
openaire   +1 more source

(135) Post-Finasteride Syndrome: A Case Presentation and Discussion

Journal of the Academy of Consultation-Liaison Psychiatry, 2022
Daniel Wesley, Rachel Bronsther
openaire   +1 more source

Home - About - Disclaimer - Privacy